Bio Green Med Solution, Inc.BGMSPEarnings & Financial Report
Nasdaq
NextNov 26, 2026
BGMSP Q3 2025 Key Financial Metrics
Revenue
$81.0K
Gross Profit
N/A
Operating Profit
$-992.0K
Net Profit
$-988.0K
Gross Margin
N/A
Operating Margin
-1224.7%
Net Margin
-1219.8%
YoY Growth
710.0%
EPS
$-1.31
Financial Flow
Bio Green Med Solution, Inc. Q3 2025 Financial Summary
Bio Green Med Solution, Inc. reported revenue of $81.0K for Q3 2025, with a net profit of $-988.0K (-1219.8% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $81.0K |
|---|---|
| Net Profit | $-988.0K |
| Gross Margin | N/A |
| Operating Margin | -1224.7% |
| Report Period | Q3 2025 |
Bio Green Med Solution, Inc. Annual Revenue by Year
Bio Green Med Solution, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $43.0K).
| Year | Annual Revenue |
|---|---|
| 2024 | $43.0K |
| 2023 | $420.0K |
| 2022 | $0 |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $31000 | $29000 | $4000 | $10000 | $0 | $6000 | $2000 | $81000 |
| YoY Growth | N/A | N/A | -98.9% | -37.5% | N/A | -79.3% | -50.0% | 710.0% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $8.8M | $6.2M | $8.2M | $5.4M | $4.1M | $3.7M | $4.4M | $8.2M |
| Liabilities | $8.2M | $8.4M | $7.2M | $6.4M | $6.3M | $672000 | $770000 | $1.1M |
| Equity | $607000 | $-2.2M | $999000 | $-970000 | $-2.2M | $3.1M | $3.6M | $7.1M |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-3.9M | $-483000 | $-3.1M | $-3.1M | $-1.4M | $-3.2M | $-1.1M | $-434000 |